
A new molecular glue reprograms the lymphoma protein BCL6 to switch cancer-cell death back on, clearing aggressive tumors in mice in just 11 days.
Syndicated via official news feed
Syndicated feed content with full publisher credit.
Continue reading verified coverage and related developments on this desk.
Latest developments and reports from the desk
Regulator may propose changes to the way settlement prices for equity derivatives contracts are calculated.
Bathla Group’s administrator gave a breakdown of known creditors for the first time as talks remain ongoing to stave of liquidation at the embattled Sydney property developer.
Roche Holding AG plans to deploy new laboratory equipment in the epicenter of the Democratic Republic of Congo’s Ebola epidemic as authorities struggle to contain a virus that has repeatedly outrun the response.